204 related articles for article (PubMed ID: 37524243)
1. Chaperone-mediated autophagy dysregulation during aging impairs hepatic fatty acid oxidation via accumulation of NCoR1.
Choi YJ; Yun SH; Yu J; Mun Y; Lee W; Park CJ; Han BW; Lee BH
Mol Metab; 2023 Oct; 76():101784. PubMed ID: 37524243
[TBL] [Abstract][Full Text] [Related]
2. SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation.
Lee W; Kim HY; Choi YJ; Jung SH; Nam YA; Zhang Y; Yun SH; Chang TS; Lee BH
Theranostics; 2022; 12(5):2351-2369. PubMed ID: 35265214
[No Abstract] [Full Text] [Related]
3. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
4. Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
6. LAMP2A, and other chaperone-mediated autophagy related proteins, do not decline with age in genetically heterogeneous UM-HET3 mice.
Zhang KK; Zhang P; Kodur A; Erturk I; Burns CM; Kenyon C; Miller RA; Endicott SJ
Aging (Albany NY); 2023 Jun; 15(11):4685-4698. PubMed ID: 37315291
[TBL] [Abstract][Full Text] [Related]
7. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma.
Liu H; Yong Y; Li X; Ye P; Tao K; Peng G; Mo M; Guo W; Chen X; Luo Y; Lin Y; Qiu J; Zhang Z; Ding L; Zhou M; Yang X; Lu L; Yang Q; Xu P
Neurosci Bull; 2022 Jun; 38(6):637-651. PubMed ID: 35267139
[TBL] [Abstract][Full Text] [Related]
9. Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.
Robert G; Jacquel A; Auberger P
Cells; 2019 Oct; 8(10):. PubMed ID: 31623164
[TBL] [Abstract][Full Text] [Related]
10. Chaperone-mediated autophagy protects cardiomyocytes against hypoxic-cell death.
Ghosh R; Gillaspie JJ; Campbell KS; Symons JD; Boudina S; Pattison JS
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1555-C1575. PubMed ID: 35584327
[TBL] [Abstract][Full Text] [Related]
11. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD.
Ma SY; Sun KS; Zhang M; Zhou X; Zheng XH; Tian SY; Liu YS; Chen L; Gao X; Ye J; Zhou XM; Wang JB; Han Y
Liver Int; 2020 Oct; 40(10):2427-2438. PubMed ID: 32339374
[TBL] [Abstract][Full Text] [Related]
13. A Fluorogenic-Based Assay to Measure Chaperone-Mediated Autophagic Activity in Cells and Tissues.
Jonnavithula A; Tandar M; Umar M; Orton SN; Woodrum MC; Mookherjee S; Boudina S; Symons JD; Ghosh R
bioRxiv; 2023 Dec; ():. PubMed ID: 38168260
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of chaperone-mediated autophagy in human diseases.
Liao Z; Wang B; Liu W; Xu Q; Hou L; Song J; Guo Q; Li N
Mol Cell Biochem; 2021 Mar; 476(3):1439-1454. PubMed ID: 33389491
[TBL] [Abstract][Full Text] [Related]
15. Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases.
Yang M; Luo S; Chen W; Zhao L; Wang X
Curr Med Chem; 2023; 30(16):1887-1899. PubMed ID: 35959621
[TBL] [Abstract][Full Text] [Related]
16. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
17. Chaperone-Mediated Autophagy after Spinal Cord Injury.
Handa K; Kanno H; Matsuda M; Sugaya T; Murakami T; Prudnikova M; Ozawa H; Itoi E
J Neurotrauma; 2020 Aug; 37(15):1687-1695. PubMed ID: 32233738
[TBL] [Abstract][Full Text] [Related]
18. Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities.
Wang YT; Lu JH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883693
[TBL] [Abstract][Full Text] [Related]
19. Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders.
Hosaka Y; Araya J; Fujita Y; Kuwano K
Inflamm Regen; 2021 Oct; 41(1):29. PubMed ID: 34593046
[TBL] [Abstract][Full Text] [Related]
20. Chaperone-mediated autophagy (CMA) alleviates cognitive impairment by reducing neuronal death in sepsis-associated encephalopathy (SAE).
Li Y; Fan Z; Jia Q; Ma H; Wu Y; Guo X; Du L; Wang X; Hou W; Fang Z; Zhang X
Exp Neurol; 2023 Jul; 365():114417. PubMed ID: 37085004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
